Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,909
Total Claims
$970K
Drug Cost
375
Beneficiaries
$2,587
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 44,021 Emergency Medicine providers
-71%
Opioid rate vs peers
2.8% vs 9.4% avg
+976%
Brand preference vs peers
16.0% vs 1.5% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
329
Opioid Claims
$16K
Opioid Cost
31.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,885 claims · $725K
Generic: 9,920 claims · $237K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 290 | $84K |
| Tirzepatide | 71 | $65K |
| Sacubitril/Valsartan | 125 | $44K |
| Finerenone | 127 | $42K |
| Dulaglutide | 49 | $35K |
| Empagliflozin | 69 | $30K |
| Insulin Detemir | 58 | $30K |
| Dolutegravir Sodium | 25 | $26K |
| Dapagliflozin Propanediol | 39 | $21K |
| Semaglutide | 19 | $19K |
| Rilpivirine Hcl | 27 | $18K |
| Cariprazine Hcl | 25 | $17K |
| Mirabegron | 51 | $16K |
| Fluticasone/Vilanterol | 37 | $15K |
| Rivaroxaban | 56 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
68%
Female
1.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About